Effect of voltage escalation and shock wave rate during stone treatment

Completed

• Conditions: Urological and Genital Diseases; rinary stone treatment with shock wave lithotripsy; Calculus of lower urinary tract

• Registration Number: ISRCTN95762080
• Lead Sponsor: Inselspital, University Hospital Berne (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07-06
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 640

Inclusion Criteria

1. Patients with renal or ureteral stones scheduled for shock wave lithotripsy
2. Patients > 20 years of age
3. Informed consent

Exclusion Criteria

1. Pregnancy
2. < 20y of age
3. Anticoagulation or aspirin medication
4. Urinary tract infection
5. Stones > 2cm (indication for Percutaneous Nephrolithotomy [PCNL] or Ureteroscopic stone treatment)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stone disintegration/stone clearance after 3 months<br>

Secondary Outcome Measures

Name	Time	Method
1. Secondary treatments or interventions for the same stone<br>2. Perirenal/subcapsular hematomas<br>3. Complications according to the Dindo-Clavien system<br>4. Microalbumin and Beta-2 microglobulin measurement as a marker of renal damage (proximal tubulus/glomerular)<br>Outcomes will be measured at 1 day and 3 months after the intervention.